Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Isotopic Labeling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Explore advanced synthesis of deuterated 2-phenylthiazole compounds for gout therapy. Enhance metabolic stability and secure your API supply chain with our expert manufacturing.
Patent CN110441447B reveals enzymatic synthesis for stable isotopic standards. Achieve superior purity and supply chain reliability for LC-MS/MS veterinary residue analysis.
Novel synthesis of deuterated quinoxaline-2-carboxylic acid via SeO2 oxidation. High purity >98% for veterinary drug residue analysis.
Patent CN109879847B reveals a scalable base-catalyzed deuteration method for flavonoids like baicalein and quercetin, offering improved metabolic stability for API development.
Patent CN104557815A reveals high-purity isotope-labeled methyl furanone synthesis. Enhances GC-MS accuracy for strigolactone analysis with stable labeling.
Novel 5-step synthesis for olopatadine deuterium metabolite. High yield, mild conditions. Cost-effective supply chain solution for pharmacokinetic studies.
Novel nickel-catalyzed preparation of ring-labeled NAA with >60% total yield. Stable isotopic labeling for environmental metabolism studies. Reliable agrochemical intermediate supplier.
Patent CN101914030B reveals a high-yield route for 13C 15N glycine using bromoacetic acid and hexamethylenetetramine, ensuring >99% isotopic purity.
Patent CN101130503B details a robust synthesis route for L-Serine-15N. Achieves high 15N abundance and purity for reliable supply chain integration.
Patent CN109096126B details a mild, high-yield synthesis for D9-Clenbuterol. Discover cost-effective production strategies for high-purity isotopic standards.
Novel 7-step route for D6-Ritonavir using isobutyric acid-D6. Achieves >98% purity and >99% isotope abundance for metabolic studies.
Patent CN115073252B details a novel Mitsunobu synthesis for 13C-Mexaxetine. This breakthrough ensures >99% isotopic purity and streamlined purification for reliable diagnostic reagents.
Patent CN109678707B reveals a robust 4-step synthesis for D3-Salbutamol. Achieve >98% isotopic purity for food safety testing with cost-effective scalable methods.
Novel 4-step route for D3-salbutamol from ethyl salicylate. >98% purity and isotope abundance for food safety testing standards.
Efficient 4-step synthesis of Mycophenolic acid-13CD3 via Mitsunobu reaction. Cost-effective route for pharmacokinetic research intermediates.
Novel two-step route ensures stable deuteration and high purity for forensic analysis, offering significant cost and supply chain advantages for global laboratories.
Patent CN108383747B reveals a mercury-free route for 18O-labeled amides using N-halosuccinimide, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.